News
Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...
6don MSN
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal ...
Shuren, who retired from his spot leading the FDA’s Center for Devices and Radiological Health (CDRH) in 2024, said last week ...
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...
The FDA was scheduled to release its decision on Novavax’s updated, protein-based COVID-19 vaccine on April 1, but the agency ...
The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
Novavax started the week hoping the FDA would issue a full approval of its Covid vaccine. But the decision never came.
The US drug regulator has missed a deadline for granting full approval to Novavax's COVID-19 vaccine, the company said ...
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results